-transparent.png){kind=logo}
Fosfomycin (FMT) was first isolated in 1969 and has gained popularity in the past few decades, specifically in the treatment of uncomplicated urinary tract infection (UTI). A retrospective study was undertaken to study the pattern of FMT use in our outpatient clinics. Subjects were divided into guideline compliant (GC) and non-guideline compliant (NGC) groups, based on available guidelines. More than half of the subjects (51, 51%) fall in the NGC group. Diabetes was an independent risk factor for inappropriate FMT prescription. This represented an opportunity for antimicrobial stewardship in treating diabetic patients with uncomplicated UTI when this agent is chosen.
Related Publications
A M Alias, and
A S Shahruniza, and
H Sulaiman
January 1975,
Chemotherapy,
A M Alias, and
A S Shahruniza, and
H Sulaiman
October 2016,
BMC infectious diseases,
A M Alias, and
A S Shahruniza, and
H Sulaiman
December 2018,
Urologiia (Moscow, Russia : 1999),
A M Alias, and
A S Shahruniza, and
H Sulaiman
January 2020,
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale,
A M Alias, and
A S Shahruniza, and
H Sulaiman
March 2020,
Diagnostic microbiology and infectious disease,
A M Alias, and
A S Shahruniza, and
H Sulaiman
September 2016,
The Journal of antimicrobial chemotherapy,
A M Alias, and
A S Shahruniza, and
H Sulaiman
May 2019,
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
A M Alias, and
A S Shahruniza, and
H Sulaiman
August 2020,
The Pediatric infectious disease journal,
A M Alias, and
A S Shahruniza, and
H Sulaiman
January 2005,
Irish journal of medical science,
A M Alias, and
A S Shahruniza, and
H Sulaiman
February 2020,
Open forum infectious diseases,
